| scholarly article | Q13442814 |
| P2093 | author name string | Masaaki Ito | |
| Tetsuya Hamaguchi | |||
| Yasuhiro Shimada | |||
| Satoru Iwasa | |||
| Yukihide Kanemitsu | |||
| Hiroshi Katayama | |||
| Masayuki Ohue | |||
| Manabu Shiozawa | |||
| Junki Mizusawa | |||
| Masayoshi Yasui | |||
| Colorectal Cancer Study Group/Japan Clinical Oncology Group | |||
| P2860 | cites work | Postoperative adjuvant chemotherapy in rectal cancer operated for cure | Q24201072 |
| Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
| Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08 | Q34662825 | ||
| Mesorectal excision for rectal cancer | Q34726877 | ||
| Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer | Q36300533 | ||
| Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection | Q38503279 | ||
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial | Q39748379 | ||
| Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? | Q45750863 | ||
| Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project | Q46153737 | ||
| Predictors of competing mortality in advanced head and neck cancer | Q46215317 | ||
| Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial | Q50000489 | ||
| Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority tria | Q53130274 | ||
| Discrete sequential boundaries for clinical trials | Q56780258 | ||
| Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint | Q70365928 | ||
| Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer | Q71784011 | ||
| A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence | Q83334228 | ||
| Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer | Q84256165 | ||
| Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC) | Q84275106 | ||
| P433 | issue | 1 | |
| P921 | main subject | clinical oncology | Q12322152 |
| phase II clinical trial | Q42824440 | ||
| phase III clinical trial | Q42824827 | ||
| P304 | page(s) | 84-87 | |
| P577 | publication date | 2016-09-21 | |
| P1433 | published in | Japanese Journal of Clinical Oncology | Q2231629 |
| P1476 | title | A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study) | |
| P478 | volume | 47 |
| Q55467667 | Feasibility of Extended Dissection of Lateral Pelvic Lymph Nodes During Laparoscopic Total Mesorectal Excision in Patients with Locally Advanced Lower Rectal Cancer: A Single-Center Pilot Study After Neoadjuvant Chemotherapy. |
| Q57168910 | Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial? |
| Q52728758 | Message from the New Editor-in-Chief. |
Search more.